Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Director · EXECUTIVE CHAIRMAN | November 10, 2021 | December 08, 2021 |
| CATERPILLAR INCCAT · Entity 2808 | Director | March 01, 2022 | March 02, 2022 |
| MCDONALDS CORPMCD · Entity 2849 | Director | December 31, 2025 | January 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date November 10, 2021 · Filed December 08, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 3,092,852 |
Ending reported balance
After 2021-11-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-11-10 · Gift · Disposed 693 · Balance 3,103,252 Row 2 · 2021-11-12 · Gift · Disposed 10,400 · Balance 3,092,852 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 35,789 |
Reported balance
Holding disclosure · report date 2021-11-10 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 35,789 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 6, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 6, 2021.
CATERPILLAR INC
Report date March 01, 2022 · Filed March 02, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,382 |
Reported balance
After 2022-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-03-01 · Tax withholding · Disposed 293 · Balance 8,382 F1: Includes adjustments for dividends accrued. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes adjustments for dividends accrued.
MCDONALDS CORP
Report date December 31, 2025 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 23,286.12 |
Reported balance
After 2025-12-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-12-31 · Grant · Acquired 670.75 · Balance 23,286.12 F1: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors' Deferred Compensation Plan (the "Plan"). F2: Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation. F3: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board. F4: Includes shares acquired through dividend reinvestment. |
| Common StockSEC Table I · non-derivative | Direct | 5,000 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors' Deferred Compensation Plan (the "Plan").
F2: Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation.
F3: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board.
F4: Includes shares acquired through dividend reinvestment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 18, 2019 Filed Mar 20, 2019 21:29 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,754 | $78.10 | $293,187.40 |
DisclosureSEC source: 0001179110-19-004118 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,684,372 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,200 | $78.30 | $172,260.00 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 30 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,537,185 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,802 | $78.46 | $141,384.92 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 29 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,539,385 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,357 | $78.89 | $185,931.95 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 28 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,541,187 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,110 | $79.19 | $167,090.90 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 27 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,543,544 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,678 | $79.14 | $291,076.92 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 26 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,545,654 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 140 | $78.16 | $10,941.70 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 25 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,549,332 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 509 | $78.79 | $40,101.57 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 24 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,549,472 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 420 | $79.25 | $33,285.00 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 23 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,549,981 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 531 | $78.72 | $41,797.67 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 22 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,550,401 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,223 | $78.78 | $96,347.94 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 21 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,550,932 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,900 | $79.16 | $150,404.00 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 20 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,552,155 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 687 | $78.48 | $53,912.33 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 19 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,554,055 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 7,282 | $78.14 | $569,015.48 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 18 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,554,742 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $79.38 | $23,814.00 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 17 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,562,024 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 18,702 | $78.07 | $1,460,065.14 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 16 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,562,324 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $79.60 | $23,880.00 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 15 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,581,026 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,660 | $78.77 | $130,749.90 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 14 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,581,326 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,336 | $79.13 | $105,717.68 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 13 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,582,986 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,011 | $78.83 | $158,517.08 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 12 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,584,322 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 494 | $78.21 | $38,635.74 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 11 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,586,333 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 7,233 | $78.79 | $569,888.07 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 10 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,586,827 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $78.99 | $23,697.00 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 9 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,594,060 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 69 | $79.90 | $5,513.10 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 8 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,594,360 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $79.87 | $39,935.00 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 7 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,594,429 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 7,956 | $78.04 | $620,886.24 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,594,929 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,277 | $78.67 | $179,131.59 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,602,885 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 700 | $78.73 | $55,107.50 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 4 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,605,162 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,900 | $79.17 | $308,763.00 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,605,862 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,337 | $78.48 | $261,887.76 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,609,762 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 805 | $78.78 | $63,413.88 |
DisclosureSEC source: 0001179110-19-004119 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,613,099 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2 | $78.71 | $157.41 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 30 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,408,870 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1 | $79.07 | $79.07 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 29 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,408,872 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par valuef | 1,800 | $79.18 | $142,524.00 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 28 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,408,873 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 36,669 | $78.06 | $2,862,382.14 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 27 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,410,673 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $78.64 | $23,590.50 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 26 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,447,342 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $79.71 | $7,971.00 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 25 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,447,642 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,800 | $78.66 | $456,228.00 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 24 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,447,742 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 75 | $78.20 | $5,864.63 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 23 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,453,542 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,816 | $78.85 | $143,182.52 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 22 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,453,617 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,800 | $78.93 | $142,074.00 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 21 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,455,433 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,300 | $79.08 | $102,804.00 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 20 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,457,233 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $79.68 | $23,904.00 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 19 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,458,533 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,891 | $78.47 | $462,266.77 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 18 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,458,833 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,701 | $78.76 | $527,770.76 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 17 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,464,724 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $78.36 | $39,180.00 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 16 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,471,425 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,094 | $78.80 | $480,176.73 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 15 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,471,925 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,044 | $79.02 | $240,536.88 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 14 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,478,019 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $79.41 | $15,882.00 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 13 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,481,063 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,100 | $79.59 | $87,549.00 |
DisclosureSEC source: 0001179110-19-004120 · edgar.xml · nonDerivative · entry 12 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,481,263 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.